Regulation

At HIMSS23, Jodi Daniel, managing director of Crowell Health Solutions, discussed the evolving policy landscape for telehealth, remote patient monitoring and other digital health technologies as the public health emergency comes to a close.

A federal jury found three former executives guilty of defrauding investors and clients, largely pharma companies. 

The company's Auto B-line Counter product uses AI to help providers assess abnormal lung conditions.

The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.

In a letter, the senator urged the agency to scrutinize the acquisition and others like it, arguing the deal could increase costs and lower quality of care.

Tyto Insights for Wheeze Detection analyzes lung sounds for possible wheezing in adults and children 2 and older.

Scott Loughlin, partner at Hogan Lovells, discusses the Federal Trade Commission's recent enforcement action against GoodRx and what digital health companies should learn from the case.

In a proposed order, the online therapy company would also pay $7.8 million for allegedly sharing consumer data with third parties like Facebook and Snapchat for advertising purposes.

The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.

Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.